Cardiometabolic syndrome is a cluster of conditions—including obesity, hypertension, insulin resistance, and dyslipidemia—that together increase the risk of heart disease, stroke, and diabetes. Often silent in its early stages, the syndrome develops over years as immune and metabolic pathways become imbalanced.

The Cardiometabolic Syndrome-Dx service leverages IMMUNOMET-Dx biomarker analysis to identify molecular patterns of systemic dysfunction long before complications arise. This empowers patients and physicians to intervene early with lifestyle, nutritional, and therapeutic strategies.

Why This Test Matters

Key Benefits

Standard scans can miss early metabolic and vascular changes. Cardiometabolic Syndrome-Dx detects these disruptions at the molecular level so patients and clinicians can act early.

Early Detection

Identifies preclinical signs of cardiometabolic dysfunction.

Comprehensive Assessment

Provides an integrated view of metabolic, vascular, and inflammatory markers.

Personalized Care

Supports tailored prevention and treatment strategies.

Ongoing Monitoring

Enables objective tracking of lifestyle and therapeutic interventions.

Physician-Ready Report Included

Results in
10-14 days

Reliable Results You Can Trust

Biomarkers Assessed

The Cardiometabolic Syndrome-Dx panel measures a targeted range of biomarkers to detect subtle metabolic and vascular changes:

  • Insulin resistance indicators (e.g., fasting insulin, HOMA-IR biomarkers)

  • Lipid metabolism markers (HDL, LDL subfractions, triglyceride-related proteins)

  • Inflammatory cytokines (IL-6, CRP, TNF-α)

  • Vascular dysfunction markers (endothelial injury proteins, nitric oxide metabolism)

  • Adipokines and obesity-associated biomarkers (leptin, adiponectin)

Download a Sample Report

How It Works

Process

From registration to results, the process is simple, secure, and stress-free. One blood draw gives you answers that imaging can’t.

01

Order & Registration

Register securely through the Persona Biomed portal.

02

Sample Collection

Standard blood draw at an approved site or via mobile phlebotomy.

03

Laboratory Analysis

High-sensitivity molecular assays analyze immune-metabolic biomarkers.

04

Results Delivery

Detailed report accessible in the patient portal with physician interpretation and AI-powered patient summary.

Who Should Consider This Test

who is this for

This test is intended for individuals who may be at risk, are experiencing related symptoms, or wish to take a proactive approach to their health, such as:

  • Adults with obesity, prediabetes, or metabolic syndrome risk factors.

  • Patients with a family history of cardiovascular disease or type 2 diabetes.

  • Individuals with hypertension or abnormal cholesterol profiles.

  • Patients seeking to measure the effectiveness of lifestyle or therapeutic interventions.

Register Now for
Cardiometabolic Syndrom-Dx

Register now for Cardiometabolic Syndrome-Dx to uncover hidden risks and take control of your long-term cardiovascular and metabolic health.

Register now